Patient Guide: A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 11 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04980872
Status: ACTIVE_NOT_RECRUITING
Condition: PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Phase: PHASE2

Find a Study Location Near You

This study is available at 11 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Atlanta, Georgia
  • Boston, Massachusetts
  • Cincinnati, Ohio
  • • And 8 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily